EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA

Immunotherapy has revolutionized the treatment of many tumors. However, most glioblastoma (GBM) patients have not, so far, benefited from such successes. With the goal of exploring ways to boost anti-GBM immunity, we developed a B-cell-based vaccine (B(Vax)) that consists of 4-1BBL(+) B cells activa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Lee Chang, Catalina, Miska, Jason, Hou, David, Rashidi, Aida, Zhang, Peng, Burga, Rachel, Torres, Ignacio Jusue, Xiao, Ting, Arrieta, Victor, Zhang, Daniel, Lopez-Rosas, Aurora, Han, Yu, Sonabend, Adam, Horbinski, Craig, Stupp, Roger, Balyasnikova, Irina, Lesniak, Maciej
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Preclinical Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651425/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.397
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados